Jonathan at Dose of Digital talks about pharma’s fear of Facebook pages centering around 2 issues that pharma thinks require 24/7 monitoring: Adverse Events and negative publicity. I hear the same excuse on why pharma companies are so scared to look at patient comments on blogs: adverse events. I’m sorry, but adverse events are happening [...]